VECTOR BIOPHARMA
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.
VECTOR BIOPHARMA
Social Links:
Industry:
Biotechnology Life Science
Founded:
2021-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.vectorbiopharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
Google Font API Amazon HSTS Person Schema Google Google Cloud Gravatar Profiles Cloudflare Amazon S3 Ruby On Rails Token
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
EGenesis
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Transire Bio
Transire Bio offers painless delivery of injectable drugs.
Venneos GmbH
Venneos develops and markets the ‘CAN-Q‘, a silicon-chip-based imaging system for the label-free analysis of biological cells
Investors List
Versant Ventures
Versant Ventures investment in Series A - Vector BioPharma
Official Site Inspections
http://www.vectorbiopharma.com Semrush global rank: 7.86 M Semrush visits lastest month: 685
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vector BioPharma"
Vector BioPharma - Crunchbase Company Profile
Vector BioPharma may be growing as evidenced by its recent merger with Absolute Biotech, which significantly expands its capabilities as a critical …See details»
Versant Ventures Launches Vector BioPharma AG
Where he led a 2,000 member-strong R&D organization. Additionally, he holds Board positions at Phoremost, Mogrify and. at Fraunhofer Institutes Stuttgart and Leipzig. ... About Vector …See details»
Versant Ventures Launches Vector BioPharma AG
Aug 10, 2022 About Vector BioPharma Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients.See details»
Vector BioPharma - VentureRadar
" Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients. Incorporating cutting-edge …See details»
Vector Biopharma - PitchBook
Vector Biopharma General Information Description. Operator of a biopharmaceutical company intended to focus on immuno-oncology. The …See details»
Vector BioPharma launched by Versant Ventures - Swiss Biotech
Aug 24, 2022 Versant Ventures announced on August 10, 2022, the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform that is devoid …See details»
Vector BioPharma | Startup Profile and Investments
Vector BioPharma is a biopharmaceutical company established in 2021, headquartered in Switzerland, with the mission of revolutionizing drug delivery precision.The company's slogan, …See details»
Vector BioPharma - Funding, Financials, Valuation & Investors
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics. New. Resources. ... How much funding has this …See details»
Vector BioPharma becomes operational with $30 million series A
Aug 12, 2022 Versant Ventures has launched Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform devoid of viral genes. With a team of …See details»
Vector BioPharma - startup.ch
Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients. Incorporating cutting-edge platform technologies, from world-class …See details»
Vector BioPharma - Products, Competitors, Financials, Employees ...
Vector BioPharma Enters Collaboration with iBET. Jan 11, 2023. Will develop high-throughput analytical methods and scalable processes for gene delivery. 01.11.23 Vector BioPharma AG , …See details»
Vector BioPharma: the future of gene delivery
Nov 16, 2022 Precision gene delivery remains one of the greatest challenges in modern medicine. A Basel-based biopharma company, Vector BioPharma, has accepted the challenge …See details»
Vector Biopharma AG (Vector Biopharma AG) - 药物管线_专利_临 …
了解Vector Biopharma AG (Vector Biopharma AG)公司的药物管线，治疗领域，技术平台，以及它的3篇新闻。 ... a world-leading research-intensive organization specialized in biotechnology …See details»
Vector BioPharma Company Information - Funding, Investors, and …
Vector BioPharma August 2022 Series A Funding Round: $30m; 2022. Vector BioPharma Series A round, August 10, 2022 $30m. 2022. Vector BioPharma August 2022 Series A Funding …See details»
Versant invests $30M in CGT startup Vector Biopharma
Aug 16, 2022 The platform, called SHREAD — Shielded, Retargeted Adenovirus — harnesses the non-replicative, high-capacity properties of adenoviral vectors combined with exogenous, …See details»
Vector BioPharma Launches With Novel Gene Delivery Platform
Aug 10, 2022 Vector BioPharma’s platform aims at three main obstacles faced in the gene delivery field: Tissue-specific delivery of payloads, limitations on the size of genetic cargo, and …See details»
Series A - Vector BioPharma - 2022-08-10 - Crunchbase
Aug 10, 2022 Vector BioPharma raised $30000000 on 2022-08-10 in Series A. Versant Ventures Versant Ventures caters to the healthcare sector with early and later stage venture, …See details»
Vector: targeted gene delivery with immune-shielded, high …
Aug 11, 2022 Vector BioPharma AG, which debuted Wednesday, is the latest company to emerge from Versant Ventures’ Basel-based incubator Ridgeline, which provides biologists, …See details»
Vector BioPharma: resurrecting - The Plückthun Lab
Vector Biopharma, Andreas Plückthun of the University of Zurich and serial pharmaceutical executive Lorenz Mayr aim to bring adenoviruses back. In this, his fourth start-up, Plückthun …See details»
Vector BioPharma and iBET collaborate to develop high …
Jan 10, 2023 Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for …See details»